At Theragen Molecular Innovations, we deliver cutting-edge solutions that accelerate innovation and drive progress in biopharmaceutical research . Our team consists of skilled scientists and industry experts who work together to address challenges and create impactful solutions, advancing drug development and improving research process.
Using our innovative approach, we leverage the latest scientific advancements and state-of-the-art technology, we ensure that every project is executed with precision, integrity, and efficiency.
We emphasize on high-quality recombinant products including monoclonal antibodies, fragment antibodies, proteins, hormones, peptides – both novel and biosimilar. Our services include proof-of-concept, scale up, process development and optimization, and analytical support. We also extend auxiliary support to pre-clinical, and regulatory submissions.
We understand the complexities and challenges of bringing new products to market.Gain a competitive advantage with our partnership.
From preclinical research to clinical trials, we offer a range of services to support the development of cutting-edge medical treatments.
Our team possesses extensive knowledge on regulatory requirements and can provide support in preparing and submitting applications to regulatory bodies such as the Review Committee on Genetic Manipulation (RCGM) and Central Drugs Standard Control Organisation (CDSCO).
Our dedicated and efficient team, along with streamlined workflows, enable us to expedite development timelines without compromising on quality and safety.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.